@FierceMedDev: Atossa board adopts 'poison pill' remedy in wake of FDA crackdown. More | Follow @FierceMedDev
@VarunSaxena2: After months of silence, FDA returns to name and shame strategy on pediatric trial compliance. Story | Follow @VarunSaxena2
@MichaelGFierce: Smallest, fastest nanomotor moves drugs and releases them on demand. Article | Follow @MichaelGFierce
@EmilyWFierce: Doctors in Italy designed a mini dialysis machine that could save the lives of infants. More | Follow @EmilyWFierce
> GE Capital led a $32 million funding round for Mason, OH, based diagnostic company Assurex Health. Story
> BTG International received 510(k) clearance for its EkoSonic Endovascular System for the treatment of pulmonary embolism. Release
> The FDA's recently released final guidance on transferring the oversight of clinical trials to another institutional review board contains only small changes from the draft version. Story
Biotech News
@FierceBiotech: This week's EuroBiotech Report: AZ and Europe's 'innovation malaise,' €30M Irish life sci fund, and more. Report | Follow @FierceBiotech
@JohnCFierce: So, something has changed at the CHMP on conditional approvals, and I don't know what it is. Can anyone fill in the blanks here? | Follow @JohnCFierce
@DamianFierce: PTC convinces CHMP to change its mind on conditional approval of the DMD drug ataluren. Story | Follow @DamianFierce
@EmilyMFierce: Beware! Crackpot science: Article. File under: Why I don't watch TV news. | Follow @EmilyMFierce
> Lilly, Boehringer pick up EU nod for FDA-spurned diabetes treatment. More
> The EU's not impressed with Novartis' 'breakthrough' cardio drug, either. Story
> Former CDER official joins Greenleaf Health, biosimilars experience in tow. Chutes & Ladders
Pharma News
@FiercePharma: Takeda now 5 for 6 in winning Actos cases, but that loss was a stunner. Article | Follow @FiercePharma
@TracyStaton: Some AstraZeneca investors are balking at the board's Pfizer snub. Others are practically high-fiving Chairman Johannson. Story | Follow @TracyStaton
@EricPFierce: So you thought you would get through the holidays without more Pfizer/AstraZeneca news? Not a chance. More | Follow @EricPFierce
@CarlyHFierce: Ok, this Rolaids-sponsored spelling bee just passed vaccine car seats for my favorite thing today. Article | Follow @CarlyHFierce
> Roche gets thumbs up for CLL use of Gazyvaro in EU. News
> California goes after Purdue, Endo, J&J, Actavis and Teva over opioids. More